Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
Group letter to White House urging immediate action to pause Medicaid redeterminations in states where individuals are losing access to coverage for procedural reasons, protecting Medicaid patients' access to care.
Group letter in support of the Accelerating Kids' Access to Care Act, legislation to help reduce the time it currently takes children covered by Medicaid or the Children’s Health Insurance Program (CHIP) to access specialized care when providers in their home state cannot address their care needs.
Brief to assist the Court in understanding the nature and extent of the harms that surprise billing has caused to patients and customers, and the common-sense regulation of the independent dispute resolution ("IDR") process necessary to fulfill the No Surprise Act's central purpose of reducing health care costs for consumers.
Letter to CMS urging the department to implement protections to ensure that UM is used only in situations where it is clinically appropriate, does not create undue delays or changes in care that may harm patient outcomes, and that UM requirements do not reset when switching insurance providers.
Letter to ICER urging the use of a patient and people with disabilities centered value framework in the 2024 Value Assessment Framework, increasing accessibility and equity.
Public Input Comment to CMS, urging the reversal of the decision to element procedure code S2068 for deep inferior epigastric perforator (DIEP) flap breast reconstruction surgery.
Letter supporting the implementation of the New York Section 1322 State Innovation waiver to expand its Essential Plan to more New Yorkers, reducing the numbers of uninsured individuals, substantially lowering healthcare costs, and improving health equity, while still satisfying federal guardrails protections.
Letter endorsing H.R. 1843 / S. 1001 which would permanently exempt high deductible health plans from the requirement of a deductible for telehealth and other remote care services.
Letter to House and Senate Leadership urging Congress to protect patient access and quality care for Medicare beneficiaries by keeping providers whole in Medicare’s drug price negotiation process and removing them from the middle of this negotiation process.
Letter urging HHS to protect access to care in the Medicaid program by immediately pausing redeterminations in states where individuals are overwhelmingly losing coverage for procedural reasons.